Patient-reported penicillin or cephalosporin allergy is associated with inappropriate prescribing, adverse outcomes, and antibiotic resistance and is encountered in up to 1 in 4 hospitalized patients. These allergies are frequently “unknown” and not well clarified by healthcare workers. The high prevalence of potentially misleading penicillin or cephalosporin allergy labels is confounded by poor clinical understanding of beta-lactam prescribing in penicillin/cephalosporin allergy and no comprehensive clinical decision-making tools to delabel these patients.

PENallergy✔ was developed to fill this significant void in patient care and safety by providing a comprehensive, evidence-based and user-friendly program using clinical decision-making tools to delabel allergic patients. The toolkits are supported by an extensive educational component, answers to common FAQs, and thorough up-to-date references. Individualized hospital metrics are also available for use by the Antimicrobial Stewardship Team for quality assurance data.

PENallergy✔ was developed with Infectious Disease physicians, pediatricians, clinical pharmacists, hospitalists, and advanced practice providers and is intended to be used by all healthcare professionals - physicians, pharmacists, nurses, advanced practice providers, and medical students in all hospital sizes from Critical Access to University teaching hospitals.